437 related articles for article (PubMed ID: 21729181)
1. Mechanisms of immunotherapy to wasp and bee venom.
Ozdemir C; Kucuksezer UC; Akdis M; Akdis CA
Clin Exp Allergy; 2011 Sep; 41(9):1226-34. PubMed ID: 21729181
[TBL] [Abstract][Full Text] [Related]
2. Expansion of circulating Foxp3+)D25bright CD4+ T cells during specific venom immunotherapy.
Pereira-Santos MC; Baptista AP; Melo A; Alves RR; Soares RS; Pedro E; Pereira-Barbosa M; Victorino RM; Sousa AE
Clin Exp Allergy; 2008 Feb; 38(2):291-7. PubMed ID: 18070166
[TBL] [Abstract][Full Text] [Related]
3. Immunoblot studies in allergic patients to hymenoptera venom before and during immunotherapy.
Pereira Santos MC; Pedro E; Spínola Santos A; Branco Ferreira M; Palma Carlos ML; Palma Carlos AG
Eur Ann Allergy Clin Immunol; 2005 Sep; 37(7):273-8. PubMed ID: 16285233
[TBL] [Abstract][Full Text] [Related]
4. Insect venom immunotherapy induces interleukin-10 production and a Th2-to-Th1 shift, and changes surface marker expression in venom-allergic subjects.
Bellinghausen I; Metz G; Enk AH; Christmann S; Knop J; Saloga J
Eur J Immunol; 1997 May; 27(5):1131-9. PubMed ID: 9174602
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of allergen-specific immunotherapy: T-regulatory cells and more.
Verhagen J; Blaser K; Akdis CA; Akdis M
Immunol Allergy Clin North Am; 2006 May; 26(2):207-31, vi. PubMed ID: 16701141
[TBL] [Abstract][Full Text] [Related]
6. [The basophilic histamine liberation test as a diagnostic method in Hymenoptera venom allergy].
Przybilla B; Ring J; Wielgosch J
Hautarzt; 1988 Oct; 39(10):662-70. PubMed ID: 2466814
[TBL] [Abstract][Full Text] [Related]
7. High sensitivity of basophils predicts side-effects in venom immunotherapy.
Kosnik M; Silar M; Bajrovic N; Music E; Korosec P
Allergy; 2005 Nov; 60(11):1401-6. PubMed ID: 16197472
[TBL] [Abstract][Full Text] [Related]
8. Hymenoptera Venom Allergy: How Does Venom Immunotherapy Prevent Anaphylaxis From Bee and Wasp Stings?
Sahiner UM; Durham SR
Front Immunol; 2019; 10():1959. PubMed ID: 31497015
[TBL] [Abstract][Full Text] [Related]
9. Humoral immunological response in patients with venom allergy during specific immunotherapy.
Szymański W; Chyrek-Borowska S
Rocz Akad Med Bialymst; 1995; 40(2):376-82. PubMed ID: 8834621
[TBL] [Abstract][Full Text] [Related]
10. Bee venom immunotherapy results in decrease of IL-4 and IL-5 and increase of IFN-gamma secretion in specific allergen-stimulated T cell cultures.
Jutel M; Pichler WJ; Skrbic D; Urwyler A; Dahinden C; Müller UR
J Immunol; 1995 Apr; 154(8):4187-94. PubMed ID: 7706753
[TBL] [Abstract][Full Text] [Related]
11. Patients still reacting to a sting challenge while receiving conventional Hymenoptera venom immunotherapy are protected by increased venom doses.
Ruëff F; Wenderoth A; Przybilla B
J Allergy Clin Immunol; 2001 Dec; 108(6):1027-32. PubMed ID: 11742283
[TBL] [Abstract][Full Text] [Related]
12. Surface membrane antigen alteration on blood basophils in patients with Hymenoptera venom allergy under immunotherapy.
Siegmund R; Vogelsang H; Machnik A; Herrmann D
J Allergy Clin Immunol; 2000 Dec; 106(6):1190-5. PubMed ID: 11112905
[TBL] [Abstract][Full Text] [Related]
13. Agreement of skin test with IL-4 production and CD40L expression by T cells upon immunotherapy of subjects with systemic reactions to Hymenoptera stings.
Urra JM; Cabrera CM; Alfaya T; Feo-Brito F
Mol Immunol; 2016 Feb; 70():134-9. PubMed ID: 26774053
[TBL] [Abstract][Full Text] [Related]
14. Diagnosis and treatment of allergy to hymenoptera venoms.
Hamilton RG
Curr Opin Allergy Clin Immunol; 2010 Aug; 10(4):323-9. PubMed ID: 20543672
[TBL] [Abstract][Full Text] [Related]
15. Hymenoptera venom allergy in humans.
Cichocka-Jarosz E
Folia Med Cracov; 2012; 52(3-4):43-60. PubMed ID: 24852686
[TBL] [Abstract][Full Text] [Related]
16. Medication with antihistamines impairs allergen-specific immunotherapy in mice.
Johansen P; Senti G; Maria Martínez Gómez J; Kündig TM
Clin Exp Allergy; 2008 Mar; 38(3):512-9. PubMed ID: 18081882
[TBL] [Abstract][Full Text] [Related]
17. Individual hymenoptera venom compounds induce upregulation of the basophil activation marker ectonucleotide pyrophosphatase/phosphodiesterase 3 (CD203c) in sensitized patients.
Binder M; Fierlbeck G; King Ti; Valent P; Bühring HJ
Int Arch Allergy Immunol; 2002 Oct; 129(2):160-8. PubMed ID: 12403934
[TBL] [Abstract][Full Text] [Related]
18. Long-term protection after stopping venom immunotherapy: results of re-stings in 200 patients.
Lerch E; Müller UR
J Allergy Clin Immunol; 1998 May; 101(5):606-12. PubMed ID: 9600496
[TBL] [Abstract][Full Text] [Related]
19. The adhesion molecule ICAM-1 is overexpressed in patients with Hymenoptera venom allergy and decreases after ultrarush venom immunotherapy.
Patella V; Incorvaia C; Ricciardi L; Florio G; Saija A; Frati F; Gangemi S
J Biol Regul Homeost Agents; 2011; 25(3):465-8. PubMed ID: 22023772
[TBL] [Abstract][Full Text] [Related]
20. Adverse reactions to venom immunotherapy.
Ramirez DA; Londono S; Evans R
Ann Allergy; 1981 Dec; 47(6):435-9. PubMed ID: 7325415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
